Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.

Barclays 28th Annual Global Healthcare Conference March 10, 2026 3:00 PM EDTCompany ParticipantsEmily Leproust ...

Methods developed and validated to establish the "World Bank of NK Cells" from healthy donors and cancer patients -- Single apheresis yields up to 5 billion (5×109) highly pure activated memory ...

In this GEN Learning Lab, our expert panelists Linda Orzolek, MS, MB, Xuhuai Ji, MD, PhD, and Christina Chang, PhD, will discuss the current landscape of imaging- and next-generation sequencing-based ...

The team, which is led from Institut Imagine by Paul Bastard, will receive up to $25m over approximately five years to take on the challenge of cancer avoidance.

Background Chromosome 19 is the most gene-dense chromosome in the human genome, with a high frequency of segmental ...

Researchers at Duke-NUS Medical School have identified a molecular switch controlled by the protein GATA6 that determines whether pancreatic cancer cells respond to chemotherapy or become resistant.

To address the demand for rapid, highly specific therapeutic candidates, Creative Biolabs has optimized its comprehensive suite of antibody discovery platforms.

The compounds have exploded in popularity, but big questions about safety and effectiveness are still unresolved. MIT Technology Review Explains: Let our writers untangle the complex, messy world of ...

Peptides are emerging as one of the wellness industry’s newest obsessions, with influencers as their greatest champions. While the hormone-related formulations have, in some cases, been approved by ...

Silicon Valley’s biohacking obsession with poorly-studied chemical substances has reached its logical endpoint: they’re now buying peptides on Temu. To understand why that matters, it helps to know a ...